Controlled Release Drug Delivery Market by Technology Outlook (Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, and Others), and Application (Injectables, Drug Eluting Stents, Oral Controlled, Transdermal and Ocular Patches, Infusion Pumps, and Metered Dose Inhalers), and Region (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America), Global trends and forecast from 2022 to 2029

Published on: Mar 2022
From:USD $3499.00
Number Of Pages:120

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 78.41 billion	7.8%	Europe

by Technology Outlook	by Application	by Region
Wurster Technique Coacervation Micro Encapsulation Implants Transdermal Targeted Delivery Others	Metered Dose Inhalers Injectable Transdermal And Ocular Patches Infusion Pumps Oral Controlled-Drug Delivery Systems Drug Eluting Stents	North America Europe Asia Pacific South America Middle East And Africa

4.5/5 - (39 votes)

Controlled Release Drug Delivery Market Overview

The global controlled release drug delivery market size is expected to grow at 7.8% CAGR from 2022 to 2029. It is expected to reach above USD 78.41 billion by 2029 from USD 39.88 billion in 2020.

The shift in physicians’ prescription patterns towards favoring controlled release drug delivery systems over conventional methods, driven by benefits such as enhanced therapeutic efficacy, improved patient compliance, and reduced treatment costs, is anticipated to fuel market growth in the forecast period. Furthermore, pharmaceutical companies, operating in a highly competitive and fragmented market, are actively responding to evolving market needs by continuously investing in the development of controlled release drug delivery systems, thus significantly boosting demand.

Moreover, the continuous increase in research and development expenditure by pharmaceutical firms focused on developing effective therapies for chronic and non-communicable diseases such as cancer, diabetes, and hypertension is expected to drive market growth in the forecast period. For example, TAR-200 (Gemcitabine), a pipeline product from Taris, an R&D-based biomedical company, which employs a controlled release drug delivery system, shows promise for treating bladder cancer.

Controlled Release Drug Delivery Market | Exactitude Consultancy — Controlled Release Drug Delivery Technology Market | Exactitude Consultancy

Additionally, the growing global elderly and pediatric populations are significant contributors to market expansion, primarily due to the prevalent non-adherence to medication regimens in these age groups. Geriatric individuals, with compromised physical, mental, and biological functions, often struggle with medication intake, unable to tolerate high doses and severe side effects. Consequently, there is an increasing demand for controlled release drug delivery systems to accommodate the rising patient population.

The controlled release drug delivery system enables substantial reductions in dosage and frequency, prevents abnormal fluctuations in plasma drug levels, enhances efficacy, improves patient compliance, and achieves a uniform drug effect. Unlike traditional delivery systems, controlled release systems provide prolonged therapeutic effects by delivering drugs to the target site with predetermined and predictable release kinetics. Consequently, due to the numerous advantages offered by controlled release delivery systems, their adoption is anticipated to increase significantly.

Controlled Release Drug Delivery Market Segment Analysis

The global controlled release drug delivery Industry has been categorized by technology, release mechanism, application. In terms of technology, the market can be divided into Wurster technique, micro encapsulation, coacervation, transdermal, targeted delivery, and others.

Because a large number of market participants have a strong portfolio in the technology, the targeted delivery segment is projected to hold a major share of the market. The controlled release drug delivery market can be divided into micro reservoir feedback regulated, activation modulated, partition controlled, chemically activated systems, and polymer matrix systems, depending on the release method. The market is divided into metered dosage inhalers, injectables, oral controlled, drug eluting stents, transdermal, infusion pumps, and ocular patches based on application. Because of the widespread use and availability of oral controlled release drug delivery systems, the oral controlled segment is likely to dominate the global market.

On the basis of rot of administration, the global controlled release drug delivery market is classified into oral, injectable, ocular, nasal, topical and implantable. The injectable segment is sub categories into polymer-based drug delivery systems, micro-reservoir partition-controlled drug delivery systems, feedback-regulated drug delivery systems, activation modulated drug delivery systems, and chemically activated controlled drug delivery systems.

Controlled Release Drug Delivery Market Players

Healthare companies to small ones, many companies are actively working in the global controlled release drug delivery market. These key players include, are Orbis Biosciences, Inc., Merck and Co., Inc., Alkermes plc, Johnson and Johnson, Coating Place, Inc., Corium International, Inc., Depomed, Inc., Pfizer, Inc, Aradigm Corporation, Capsugel and others.

Companies are mainly in the life sciences manufacturing and they are competing closely with each other. Innovation is one of the most important and key strategy as it has to be for any controlled release drug delivery market. However, companies in the market have also opted and successfully driven inorganic growth strategies like mergers & acquisition and so on.

In 2022 – Innocan Pharma Corporation has announced that Innocan’s CBD LPT injection offered as a treatment for a dog going through osteoarthritis of the hip and elbow joint caused a reduction in pain and enhanced activity and vitality.
In 2022- Massachusetts General Hospital has announced the testing of Tonix Pharmaceuticals nasally delivered potentiated oxytocin TNX-1900 to treat a continuous eating disorder. Tonix is developing TNX-1900 to treat chronic migraine.

In 2022 – A developer and manufacturer of innovative delivery formulations, Cure Pharmaceutical and Milagro Pharmaceuticals have partnered with each other to register and sell some of CURE’s OTC and medical compounds across Mexico. The compounds use CURE’s patented drug delivery platform for oral thin film (OTF), CUREform.

Who Should Buy? Or Key Stakeholders

Life sciences manufacturers
Controlled release drug delivery suppliers
Medical devices companies
Investors
Manufacturing companies
End user companies
Research institutes
Healthcare
Others

Key Takeaways:

The global controlled release drug delivery market size is expected to grow at 7.8%
The targeted delivery segment is projected to hold a major share of the market based on technology.
The oral controlled segment is likely to dominate the global market based on application.
North America is expected to have the biggest market share.
A notable trend in the controlled release drug delivery technology market is the increasing adoption driven by its ability to enhance therapeutic efficacy and patient compliance.

Controlled Release Drug Delivery Market Regional Analysis

The global controlled release drug delivery market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

Its major share is occupied by North America, Europe and Asia Pacific region. Europe shares 40% of total market. After that, Rest of the World 60% of global market respectively.

During the projection period, North America is expected to have the biggest market share for controlled release drug delivery owing to the growing presence of major players increase in innovation.

Inc The global controlled release drug delivery market is dominated by North America, followed by Europe. Rising research and development expenditure, the presence of key market players, the growing number of NDA and ANDA applications, the surging patient pool with chronic diseases such as diabetes requiring long-term treatment, and the growing demand for controlled-release medication are expected to enhance ethe growth of global drug release drug deliver market over the coming years. Increased research and development expenditures by businesses would boost market growth across the area. The Europe is a major player in the global controlled release drug delivery market. Due to increasing urbanization, technological advancements, and increased expenditures in end-use industries, the Europe region is the leading country in the controlled release drug delivery market.

The controlled release drug delivery market in Asia Pacific is estimated to grow rapidly during over the coming years owing to rapid population, rising old age population, and rapidly expanding pharmaceutical business in the region. Therefore, growing concentration of manufacturers for business expansion due to low manufacturing cost propels the growth of the controlled release drug delivery market in Asia Pacific.

Key Market Segments: Global Controlled Release Drug Delivery Market

Global Controlled Release Drug Delivery Technology Market by Technology Outlook, 2020-2029, (USD Million) (Thousand Units)

Wurster Technique
Coacervation
Micro Encapsulation
Implants
Transdermal
Targeted Delivery
Others

Global Controlled Release Drug Delivery Technology Market by Application, 2020-2029, (USD Million) (Thousand Units)

Metered Dose Inhalers
Injectable
Transdermal And Ocular Patches
Infusion Pumps
Oral Controlled-Drug Delivery Systems
Drug Eluting Stents

Global Controlled Release Drug Delivery Technology Market by Region, 2020-2029, (USD Million) (Thousand Units)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important Countries In All Regions Are Covered.

Key Question Answered

What are the growth opportunities related to the adoption of controlled release drug delivery market across major regions in the future?
What are the new trends and advancements in the controlled release drug delivery market?

Which product categories are expected to have highest growth rate in the controlled release drug delivery market?

Which are the key factors driving the controlled release drug delivery market?
What will the market growth rate, growth momentum or acceleration the market carries during the forecast period?

Introduction
1. Market Definition
2. Market Segmentation
3. Research Timelines
4. Assumptions and Limitations
Research Methodology
1. Data Mining
  1. Secondary Research
  2. Primary Research
  3. Subject-Matter Experts’ Advice
2. Quality Checks
  1. Final Review
3. Data Triangulation
  1. Bottom-Up Approach
  2. Top-Down Approach
  3. Research Flow
4. Data Sources
Executive Summary
Market Overview
1. Global Controlled Release Drug Delivery Market Outlook
  1. Market Drivers
  2. Market Restraints
  3. Market Opportunities
2. Impact of Covid-19 On Global Controlled Release Drug Delivery Market
Global Controlled Release Drug Delivery Market by Technology Outlook, (USD Million) (Thousand Units)
1. Wurster Technique
2. Coacervation
3. Micro Encapsulation
4. Implants
5. Transdermal
6. Targeted Delivery
7. Others
Global Controlled Release Drug Delivery Market by Application, (USD Million) (Thousand Units)
1. Metered Dose Inhalers
2. Injectable
3. Transdermal and Ocular Patches
4. Infusion Pumps
5. Oral Controlled-drug Delivery Systems
6. Drug Eluting Stents
Global Controlled Release Drug Delivery Market by Region, (USD Million) (Thousand Units)
1. Introduction
2. Asia-Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Australia
  6. South-East Asia
  7. Rest of Asia-Pacific
3. North America
  1. United States
  2. Canada
  3. Mexico
4. Europe
  1. Germany
  2. United Kingdom
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Rest of Europe
5. South America
  1. Brazil
  2. Argentina
  3. Colombia
  4. Rest of South America
6. Middle- East and Africa
  1. UAE
  2. Saudi Arabia
  3. South Africa
  4. Rest of Middle- East and Africa
Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)
1. Orbis Biosciences, Inc.
2. Merck and Co., Inc.
3. Alkermes plc
4. Johnson and Johnson
5. Coating Place, Inc.
6. Corium International, Inc.
7. Depomed, Inc.
8. Pfizer, Inc
9. Aradigm Corporation
10. Capsugel
11. Others

*The Company List Is Indicative

LIST OF TABLES

TABLE 1 GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 2 GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 3 GLOBALSILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 4 GLOBAL SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 5 GLOBAL SILICON ADDITIVES MARKET BY REGION (USD MILLIONS), 2020-2029

TABLE 6 GLOBAL SILICON ADDITIVES MARKET BY REGION (THOUSAND UNITS), 2020-2029

TABLE 7 NORTH AMERICA SILICON ADDITIVES MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 8 NORTH AMERICA SILICON ADDITIVES MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 9 NORTH AMERICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 10 NORTH AMERICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 11 NORTH AMERICA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 12 NORTH AMERICA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 13 US CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 14 US CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 15 US SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 16 US SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 17 CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (MILLIONS), 2020-2029

TABLE 18 CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 19 CANADA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 20 CANADA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 21 MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 22 MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 23 MEXICO SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 24 MEXICO SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 25 SOUTH AMERICA SILICON ADDITIVES MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 26 SOUTH AMERICA SILICON ADDITIVES MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 27 SOUTH AMERICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 28 SOUTH AMERICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 29 SOUTH AMERICA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 30 SOUTH AMERICA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 31 BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 32 BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 33 BRAZIL SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 34 BRAZIL SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 35 ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 36 ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 37 ARGENTINA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 38 ARGENTINA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 39 COLOMBIA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 40 COLOMBIA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 41 COLOMBIA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 42 COLOMBIA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 43 REST OF SOUTH AMERICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 44 REST OF SOUTH AMERICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 45 REST OF SOUTH AMERICA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 46 REST OF SOUTH AMERICA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 47 ASIA-PACIFIC SILICON ADDITIVES MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 48 ASIA-PACIFIC SILICON ADDITIVES MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 49 ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 50 ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 51 ASIA-PACIFIC SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 52 ASIA-PACIFIC SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 53 INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 54 INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 55 INDIA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 56 INDIA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 57 CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 58 CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 59 CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 60 CHINA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 61 CHINA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 62 JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 63 JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 64 JAPAN SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 65 JAPAN SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 66 SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 67 SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 68 SOUTH KOREA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 69 SOUTH KOREA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 70 AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 71 AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 72 AUSTRALIA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 73 AUSTRALIA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 74 SOUTH EAST ASIA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 75 SOUTH EAST ASIA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 76 SOUTH EAST ASIA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 77 SOUTH EAST ASIA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 78 REST OF ASIA PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 79 REST OF ASIA PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 80 REST OF ASIA PACIFIC SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 81 REST OF ASIA PACIFIC SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 82 EUROPE SILICON ADDITIVES MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 83 EUROPE SILICON ADDITIVES MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 84 EUROPE CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 85 EUROPE CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 86 EUROPE SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 87 EUROPE SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 88 GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 89 GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 90 GERMANY SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 91 GERMANY SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 92 UK CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 93 UK SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 94 UK SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 95 UK SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 96 FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 97 FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 98 FRANCE SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 99 FRANCE SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 100 ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 101 ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 102 ITALY SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 103 ITALY SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 104 SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 105 SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 106 SPAIN SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 107 SPAIN SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 108 RUSSIACONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 109 RUSSIACONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 110 RUSSIASILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 111 REST OF EUROPE CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 112 REST OF EUROPE CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 113 REST OF EUROPE SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 114 REST OF EUROPE SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 115 MIDDLE EAST AND AFRICA SILICON ADDITIVES MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 116 MIDDLE EAST AND AFRICA SILICON ADDITIVES MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 117 MIDDLE EAST AND AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 118 MIDDLE EAST AND AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 119 MIDDLE EAST AND AFRICA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 120 MIDDLE EAST AND AFRICA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 121 UAE CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 122 UAE CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 123 UAE SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 124 UAE SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 125 SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 126 SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 127 SAUDI ARABIA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 128 SAUDI ARABIA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 129 SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK MILLIONS 2020-2029

TABLE 130 SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 131 SOUTH AFRICA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 132 SOUTH AFRICA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 133 REST OF MIDDLE EAST AND AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (USD MILLIONS), 2020-2029

TABLE 134 REST OF MIDDLE EAST AND AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK (THOUSAND UNITS), 2020-2029

TABLE 135 REST OF MIDDLE EAST AND AFRICA SILICON ADDITIVES MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 136 REST OF MIDDLE EAST AND AFRICA SILICON ADDITIVES MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL CONTROLLED DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK, USD MILLION, THOUSAND UNITS, 2020-2029

FIGURE 9 GLOBAL CONTROLLED DRUG DELIVERY MARKET BY APPLICATION, USD MILLION, THOUSAND UNITS, 2020-2029

FIGURE 10 GLOBAL CONTROLLED DRUG DELIVERY MARKET BY REGION, USD MILLION, THOUSAND UNITS, 2020-2029

FIGURE 11 PORTER’S FIVE FORCES MODEL

FIGURE 12 GLOBAL CONTROLLED DRUG DELIVERY MARKET BY TECHNOLOGY OUTLOOK, USD MILLION, THOUSAND UNITS, 2020-2029

FIGURE 13 GLOBAL CONTROLLED DRUG DELIVERY MARKET BY APPLICATION, USD MILLION, THOUSAND UNITS, 2020-2029

FIGURE 14 GLOBAL CONTROLLED DRUG DELIVERY MARKET BY REGION, USD MILLION, THOUSAND UNITS, 2020-2029

FIGURE 15 GLOBAL CONTROLLED DRUG DELIVERY MARKET BY REGION 2021

FIGURE 16 MARKET SHARE ANALYSIS

FIGURE 17 ORBIS BIOSCIENCES, INC.: COMPANY SNAPSHOT

FIGURE 18 MERCK AND CO., INC.: COMPANY SNAPSHOT

FIGURE 19 ALKERMES PLC: COMPANY SNAPSHOT

FIGURE 20 JOHNSON AND JOHNSON: COMPANY SNAPSHOT

FIGURE 21 COATING PLACE INC.: COMPANY SNAPSHOT

FIGURE 22 CORIUM INTERNATIONAL, INC.: COMPANY SNAPSHOT

FIGURE 23 DEPOMED INC.: COMPANY SNAPSHOT

FIGURE 24 PFIZER, INC.: COMPANY SNAPSHOT

FIGURE 25 ARADIGM CORPORATION: COMPANY SNAPSHOT

FIGURE 26 CAPSUGEL: COMPANY SNAPSHOT

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT

Controlled Release Drug Delivery Market Overview

Controlled Release Drug Delivery Market Segment Analysis

Controlled Release Drug Delivery Market Players

Who Should Buy? Or Key Stakeholders

Key Takeaways:

Controlled Release Drug Delivery Market Regional Analysis

Key Market Segments: Global Controlled Release Drug Delivery Market

Key Question Answered

Table of Content

LIST OF TABLES

LIST OF FIGURES

DOWNLOAD FREE SAMPLE REPORT

Inquire for Discount

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

6 Elmore Road, Luton, Bedfordshire LU20QB, UK

Plot No. 39, SR, 10-16, NDA Pashan Rd, Bavdhan, Pune, Maharashtra 411021

Subscribe our newsletter

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT

Controlled Release Drug Delivery Market Overview

Controlled Release Drug Delivery Market Segment Analysis

Controlled Release Drug Delivery Market Players

Who Should Buy? Or Key Stakeholders

Key Takeaways:

Controlled Release Drug Delivery Market Regional Analysis

Key Market Segments: Global Controlled Release Drug Delivery Market

Key Question Answered

Table of Content

LIST OF TABLES

LIST OF FIGURES

Related Reports

DOWNLOAD FREE SAMPLE REPORT

Inquire for Discount

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure